BALAXI PHARMACEUTICALS
|
BALAXI PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹5.29 Cr | ₹29 Cr | ₹2.02 Cr | ₹57 Cr | ₹55 Cr |
| Adjustment | ₹22 Cr | ₹7.43 Cr | ₹-1.14 Cr | ₹8.03 Cr | ₹1.18 Cr |
| Changes In working Capital | ₹-27 Cr | ₹-68 Cr | ₹11 Cr | ₹-47 Cr | ₹-16 Cr |
| Cash Flow after changes in Working Capital | ₹0.22 Cr | ₹-32 Cr | ₹12 Cr | ₹18 Cr | ₹40 Cr |
| Cash Flow from Operating Activities | ₹-4.50 Cr | ₹-35 Cr | ₹4.87 Cr | ₹6.08 Cr | ₹34 Cr |
| Cash Flow from Investing Activities | ₹-21 Cr | ₹-22 Cr | ₹-1.05 Cr | ₹-11 Cr | ₹-28 Cr |
| Cash Flow from Financing Activities | ₹0.44 Cr | ₹34 Cr | ₹30 Cr | ₹26 Cr | ₹-0.16 Cr |
| Net Cash Inflow / Outflow | ₹-25 Cr | ₹-23 Cr | ₹34 Cr | ₹21 Cr | ₹5.53 Cr |
| Opening Cash & Cash Equivalents | ₹39 Cr | ₹62 Cr | ₹28 Cr | ₹7.19 Cr | ₹1.66 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
| Closing Cash & Cash Equivalent | ₹15 Cr | ₹39 Cr | ₹62 Cr | ₹28 Cr | ₹7.19 Cr |
Compare Cashflow Statement of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹120.8 Cr | 14.3% | -3.4% | -51.3% | Stock Analytics | |
| ADANI ENTERPRISES | ₹369,708.0 Cr | 5.9% | -4.2% | 10.4% | Stock Analytics | |
| ADITYA INFOTECH | ₹51,203.9 Cr | 9.5% | 5% | 193.7% | Stock Analytics | |
| AEGIS LOGISTICS | ₹41,697.1 Cr | 8.3% | -14.9% | 58.6% | Stock Analytics | |
| PREMIER ENERGIES | ₹40,038.5 Cr | 1.9% | -2.5% | -17.8% | Stock Analytics | |
| REDINGTON | ₹27,858.5 Cr | 9.1% | -12.2% | 41.7% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | 14.3% |
-3.4% |
-51.3% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses